GMP
Regulatory framework ensuring consistent pharmaceutical manufacturing quality
ISO 22301
International standard for business continuity management systems.
Quick Verdict
GMP ensures manufacturing quality and safety in pharma via preventive controls and inspections, while ISO 22301 builds business continuity resilience across sectors through BIA and testing. Companies adopt GMP for regulatory compliance and patient protection; ISO 22301 for disruption recovery and stakeholder trust.
GMP
Good Manufacturing Practice (GMP)
Key Features
- Mandates preventive controls beyond final product testing
- Requires independent quality unit for batch approval
- Integrates risk-based Quality Risk Management principles
- Enforces process validation and equipment qualification
- Demands rigorous documentation and data integrity
ISO 22301
ISO 22301:2019 Business continuity management systems
Key Features
- PDCA cycle for continual BCMS improvement
- Business Impact Analysis (BIA) and risk assessment
- Leadership commitment with policy and roles
- Operational testing of recovery strategies
- Annex SL integration with ISO 27001
Detailed Analysis
A comprehensive look at the specific requirements, scope, and impact of each standard.
GMP Details
What It Is
Good Manufacturing Practice (GMP) is a regulatory framework of minimum enforceable standards for manufacturing pharmaceuticals, biologics, and related products. It ensures products are consistently produced to meet quality, safety, and purity criteria through preventive controls spanning facilities, equipment, processes, personnel, and records. Key approach is risk-based via Quality Risk Management (QRM), emphasizing design-in quality over end-testing.
Key Components
- Core pillars: 5 Ps (People, Premises, Processes, Procedures, Products)
- Elements include quality systems (PQS per ICH Q10), validation, documentation (ALCOA++), CAPA, supplier controls, and audits
- Built on ICH Q9/Q10, FDA 21 CFR 210/211, EU EudraLex Vol. 4, WHO GMP
- Compliance via inspections, no central certification but enforceable regionally
Why Organizations Use It
Mandated for market access; prevents recalls, contamination, liability. Drives efficiency, supply reliability, patient protection. Builds regulator trust, reduces remediation costs, enables global trade via harmonization (PIC/S, MRAs).
Implementation Overview
Phased: gap analysis, VMP, validation (DQ/IQ/OQ/PQ), training, audits. Applies to pharma/biologics manufacturers globally; scales by size/risk. Ongoing via internal audits, management review.
ISO 22301 Details
What It Is
ISO 22301:2019 is the international certification standard for Business Continuity Management Systems (BCMS). It establishes requirements to plan, implement, monitor, and improve resilience against disruptions like cyberattacks, pandemics, and natural disasters using a PDCA (Plan-Do-Check-Act) cycle and risk-based approach.
Key Components
- 10 clauses (4-10 core): context, leadership, planning (BIA, risk assessment), support, operations (recovery strategies, testing), evaluation (audits, reviews), improvement.
- No prescriptive controls; flexible, tailored to organization.
- Built on Annex SL for integration with ISO 27001, 31000.
- 3-year certification with annual surveillance audits.
Why Organizations Use It
- Mitigates downtime, financial losses; enhances recovery (e.g., RTOs).
- Meets regulations (NIS, NIST); builds stakeholder trust, reputation.
- Provides competitive edges, lower insurance, procurement advantages.
- Fosters proactive resilience culture amid rising global risks.
Implementation Overview
- Phased: gap analysis, BIA, documentation, training, testing, audits.
- 60 days to 6 months typical; suits all sizes/sectors.
- Two-stage certification (readiness, effectiveness); tools accelerate.
Key Differences
| Aspect | GMP | ISO 22301 |
|---|---|---|
| Scope | Manufacturing controls for product quality/safety | Business continuity management system resilience |
| Industry | Pharma, biologics, food, cosmetics globally | All sectors worldwide, any organization size |
| Nature | Enforceable regulations with inspections | Voluntary certification standard |
| Testing | Process/equipment validation, audits | BIA, exercises, internal/external audits |
| Penalties | Warning letters, recalls, fines | Loss of certification, no legal penalties |
Scope
Industry
Nature
Testing
Penalties
Frequently Asked Questions
Common questions about GMP and ISO 22301
GMP FAQ
ISO 22301 FAQ
You Might also be Interested in These Articles...

The DORA 'Hot Seat' Blueprint: Preparing Leadership and the Management Body for Regulatory Interviews
Prepare your Board & Management Body for DORA audits. Master the human element: demonstrate active oversight & accountability in regulatory interviews. Get the

Measuring NIST CSF 2.0 Success: KPIs, Dashboards, and Continuous Improvement Using Tiers & Profiles
Transform NIST CSF 2.0 into quantifiable success: Define board-ready KPIs for Functions, build Profile dashboards, track Tier progression. Prove ROI amid cyber

ISO 27701 2025 Update: Navigating Standalone Certification Myths, Audit Realities, and a 90-Day PIMS Launch Plan
Debunk ISO 27701 2025 standalone certification myths vs ISO 27001. Get a 90-day PIMS launch roadmap, checklists & audit prep to certify faster amid global priva
Run Maturity Assessments with GRADUM
Transform your compliance journey with our AI-powered assessment platform
Assess your organization's maturity across multiple standards and regulations including ISO 27001, DORA, NIS2, NIST, GDPR, and hundreds more. Get actionable insights and track your progress with collaborative, AI-powered evaluations.
Check out these other Gradum.io Standards Comparison Pages
PCI DSS vs GMP
Compare PCI DSS vs GMP: Uncover key differences in payment security standards and manufacturing quality regs. Optimize compliance, cut risks—explore now!
UAE PDPL vs ISO 55001
Explore UAE PDPL vs ISO 55001: Compare data privacy laws, DPIAs/DPOs, records with asset mgmt SAMP, risks & PDCA. Align for UAE compliance success!
PDPA vs MLPS 2.0 (Multi-Level Protection Scheme)
Compare PDPA (Singapore/Thailand privacy laws) vs MLPS 2.0 (China's cybersecurity scheme). Key differences, compliance strategies & insights for Asia-Pacific data protection.